Systems and methods of use for color-coded medical instrumentation - Patents.com

Color-coded biopsy needles with echogenic coatings and textures improve the safety and accuracy of medical procedures by facilitating precise instrument positioning and lesion detection under ultrasound guidance.

JP2024541675AInactive Publication Date: 2024-11-08ポプロー スティーブン
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
JP2024533096
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-02
Filing Date
2022-01-18
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Medical procedures performed inside the body, where targets and/or instruments are not visible to the naked eye, often result in inaccurate assessments of grayscale ultrasound images, leading to potential patient injury, extended procedure times, and false negative biopsies due to difficulty in positioning instruments.

Method used

The use of color-coded medical devices, such as biopsy needles, which are coated with echogenic materials of varying echo brightness or textured surfaces, allowing for accurate identification and positioning under ultrasound guidance through color coding on a display.

Benefits of technology

Enhances safety and accuracy of medical procedures by enabling precise instrument placement, reducing the risk of injury and improving the detection of suspicious lesions, thereby minimizing false negative biopsies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541675000001_ABST
    Figure 2024541675000001_ABST
Patent Text Reader

Abstract

1. A system comprising a biopsy needle device, an ultrasound probe and a processor, wherein the biopsy needle device comprises a cannula having a distal end configured to cut a tissue sample and a trocar disposed within the cannula having a notch configured to hold a tissue sample, wherein at least one of the cannula and the trocar is separated into at least two segments comprising different echogenic coatings; an ultrasound probe; and a processor configured and arranged to collect images from the ultrasound probe and color-code the at least two segments based on at least one characteristic relating to the different echogenic coatings, surface texture, surface contour and dimensions of the biopsy device.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application claims priority to U.S. patent application Ser. No. 63 / 285,240, filed December 2, 2021, entitled "SYSTEM FOR COLOR-CODING MEDICAL INSTRUMENTATION AND METHODS OF USE," the contents of which are hereby incorporated in their entirety as if fully set forth herein.

[0002] (Technical field) The present disclosure relates generally to medical devices and, more particularly, to color-coded instrumentation, such as biopsy needle assemblies configured for use with tissue biopsy devices. [Background technology]

[0003] Background of the Disclosure Medical procedures are often performed inside the body where targets and / or instruments are not visible to the naked eye. Ultrasound is often used to provide imaging of the inside of the body before, during and after such procedures, but such imaging is often in grayscale. It is difficult for laypersons and junior trainees to accurately evaluate details from these grayscale images. In fact, depending on the situation, even experienced professionals may inaccurately pick up certain shades or tones in the grayscale images. This presents a patient safety issue and may lead to injury or death. It may also prolong the length of the procedure as the physician or operator struggles to properly position the instruments. The quality of the imaging may also lead to overlooking suspicious lesions or producing false-negative biopsies. Summary of the Invention [Means for solving the problem]

[0004] As described herein, systems and techniques are provided for color-coding medical devices to produce safer and more accurate results. To better understand the overall systems and methods, the present disclosure will be described primarily with respect to bioneedles. However, it will be understood that many variations and uses of these systems and techniques are possible. As such, the bioneedle embodiments described herein are merely illustrative and non-limiting.

[0005] The embodiments may be understood by reference to the drawings, in which like segments are designated by like numerals throughout. It will be readily understood by one of ordinary skill in the art having the benefit of this disclosure that the components of the embodiments as generally described herein and illustrated in the figures can be arranged and designated in a wide variety of different configurations. Thus, the following more detailed description of various embodiments, as represented in the figures, is not intended to limit the scope of the disclosure, but is merely representative of various embodiments. While various aspects of the embodiments are present in the drawings, the drawings need not be drawn to scale unless specifically indicated.

[0006] Various features may at times be envisioned as being grouped together in a single embodiment, figure or description thereof for purposes of streamlining the disclosure, although many of these features may be used alone and / or in combination with each other. [Brief description of the drawings]

[0007] BRIEF DESCRIPTION OF THE DRAWINGS The embodiments disclosed herein will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings, in which: The drawings depict only exemplary embodiments, which will be described with additional specificity and detail in connection with the following drawings.

[0008] [Figure 1] FIG. 1 is a perspective view of a biopsy needle device.

[0009] [Diagram 2] FIG. 2 is a cross-sectional view of the biopsy needle device of FIG. 1 with the housing lid removed.

[0010] [Diagram 3] FIG. 3 is a perspective view of a cannula of the biopsy needle device of FIGS.

[0011] [Figure 3A] FIG. 3A is a detailed view of the distal end of the cannula of FIG. 3 taken along line 3A.

[0012] [Figure 4] FIG. 4 is a perspective view of a trocar of the biopsy needle device of FIGS. 1 and 2.

[0013] [Figure 4A] FIG. 4A is a detailed view of the distal end of the trocar.

[0014] [Figure 5A] 5A-5B are perspective views of color-coded biopsy needles. [Figure 5B] 5A-5B are perspective views of color-coded biopsy needles.

[0015] [Figure 6] FIG. 6 is a schematic diagram showing a system for color coding.

[0016] [Figure 7] 7A-7B are photographs showing a breast mass biopsy without and with color coding.

[0017] [Figure 8] 8A-8B are photographs showing ultrasound-guided lymph node biopsy without and with color coding.

[0018] [Figure 9]9A-9B are graphs showing echogenicity of hardware coatings versus percentage of returned signal and other examples of biopsy devices.

[0019] [Figure 10] FIG. 10 is an example of color-coding RFID tags.

[0020] [Figure 11] 11A-11B are examples of color coding of textured needles and an ultrasound showing the same. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0021] (Detailed Description) The phrases "coupled with" and "capable of communicating with" refer to any form of interaction between two or more entities, including mechanical, electrical, magnetic, electromagnetic, fluid, and thermal interactions. Two components may be "coupled" or "capable of communicating" with one another even if they are not in direct contact with one another. For example, two components may be "coupled" or "capable of communicating" with one another through an intermediate component.

[0022] The directional terms "distal" and "proximal" are given their ordinary meaning in the art; that is, the distal end of a medical device means the end of the device furthest from the practitioner in use. The proximal end refers to the opposite end or the end closest to the practitioner in use. For example, with specific application to the needle portion of a biopsy needle device, the proximal end of the needle refers to the end closest to the handle or actuator, and the distal end refers to the opposite end, which may be inserted into the patient. Similarly, "tissue" is used in its broadest sense to refer to any tissue or material within the human or animal body, and the procedures and techniques described herein may be performed in vivo or in vitro.

[0023] A tissue biopsy device may be configured to obtain tissue samples from various locations within a patient's body. For example, a biopsy device may include a biopsy needle device or needle assembly, which includes a tubing member, needle, trocar, cutting stylus, stylus, cannula, and / or other components configured to access and cut tissue samples in a medical procedure commonly referred to as Core Needle Biopsy. The biopsy needle device may be advanced to a location within the body through the patient's skin (percutaneous access), through an open incision, or through a body lumen or other structure. A portion of the biopsy needle device may be advanced into the lesion or target tissue. Another portion of the biopsy needle device may then be advanced into the lesion or target tissue to cut a tissue sample from the lesion or target tissue. The biopsy needle device may then be removed from the patient and the tissue sample extracted from the needle assembly for analysis. Additionally, the biopsy needle device may include a handle or actuator configured to axially displace or deflect at least a portion of the biopsy needle device, such that the biopsy needle device cuts or cuts the target tissue sample.

[0024] 1 and 2 are perspective views of biopsy needle device 100. As shown, biopsy needle device 100 may include a cannula assembly, a trocar assembly, a stylet assembly, and an actuator. The cannula assembly may include a cannula 120 and a cannula hub 121. The trocar assembly may include a trocar 140 and a trocar hub 141. The stylet assembly may include a stylet 160 and a stylet hub 161. The actuator may include a housing base 180 and a housing lid 181.

[0025] FIG. 3 is a perspective view of the cannula assembly of FIGS. 1 and 2, and FIG. 3A is a detailed view of the distal end 122 of the cannula 120 of FIG. 3. Referring now to FIGS. 3 and 3A, in some embodiments, the cannula assembly 102 may include a cannula 120 and a cannula hub 121. The cannula 120 may include an elongated tube having a distal end 122 and a proximal end 123. The diameter of the cannula 120 may range from 8 gauge to 22 gauge, including 14 gauge to 20 gauge. The lumen 124 of the cannula 120 may be sized to accommodate positioning of the trocar 140 within the lumen 124. The length of the cannula 120 may range from 100 cm to 5 cm, including 25 cm to 10 cm. The cannula 120 may preferably be manufactured from a medical grade stainless steel material.

[0026] In some embodiments, the proximal end 123 of the cannula 120 can be configured to be fixedly coupled to the cannula hub 121 such that the proximal end of the lumen 124 is open to allow passage of the trocar 140 into the lumen 124. The cannula 120 can be fixedly coupled to the cannula hub 121 using techniques known in the art such as bonding, welding, overmolding, and the like. The outer surface of the proximal end 123 of the cannula 120 can be modified to enhance the bond between the cannula hub 121 and the cannula 120. For example, the surface can be chemically or mechanically etched or textured to roughen the surface to enhance adhesion of adhesives or plastics. Alternatively, the surface can be chemically modified to enhance adhesion of adhesives or plastics.

[0027] The distal end 122 of the cannula 120 may include a bevel 125. The bevel 125 may be configured to cut or sever tissue as the cannula 120 slides along the long axis of the trocar 140. The bevel 125 may have an angle of 180 degrees to 5 degrees, including 30 degrees to 25 degrees. The bevel edge 126 may be sharp and configured to cut or sever tissue.

[0028] In an embodiment, the cannula 120 may include a plurality of indicia 135 (for clarity, not all indicia 135 are labeled) configured to indicate to the practitioner the distance the cannula 120 and trocar 140 have advanced into the body tissue. For example, each indicia 135 may be positioned 1 cm apart. Thus, when the practitioner displaces the cannula 120 and trocar 140 into the body tissue from the distal end 142 of the trocar 140 to the third indicia 135, it may indicate to the practitioner that approximately 3 cm of the trocar 140 and cannula 120 have been displaced into the body tissue. In some embodiments, the indicia 135 may include a plurality of approximately equally spaced annular lines, markings, or grooves on the outer surface of the cannula 120. In an embodiment, the indicia may include a plurality of graduations, or the indicia may not be equally spaced.

[0029] Cannula hub 121 may include a body 127, a cannula coupling 128, a cavity 129, and locking teeth 130. Cannula hub 121 may be disposed within a distal end of housing base 180 and configured to move along a longitudinal axis of housing base 180. Cannula coupling 128 may be generally cylindrical with bore 136 and a diameter capable of accommodating cannula 120 and a length capable of providing a sturdy attachment between cannula coupling 128 and cannula 120. Cannula coupling 128 may be positioned near a distal end 133 of body 127 of cannula hub 121. Cavity 129 may extend from distal end 133 of body 127 to proximal end 132 of body 127. Cavity 129 may be sized to accommodate a spring 182 configured to move cannula assembly 102 from a proximal configuration to a distal configuration. A locking mechanism, such as teeth 130 on cannula hub 121, is configured to mate with opposing locking teeth 183 on housing base 180. The mating locking teeth 130, 183 may allow actuator 108 to be tilted and cannula assembly 102 to be locked in a selected proximal position. Cannula hub 121 may further include a shoulder 134 near the proximal end 132 of body 127. Shoulder 134 may be configured to mate with hook member 153 of trocar hub 141 to allow selective positioning of cannula assembly 102 at the tilt and proximal positioning of actuator 108. Cannula hub 121 may be formed from an opaque or translucent plastic material using manufacturing techniques known in the industry, such as injection molding, casting, machining, and the like.

[0030] FIG. 4 is a perspective view of the trocar assembly 104 of FIGS. 1 and 2, and FIG. 4A is a detailed view of the distal end 142 of the trocar 140 of FIG. 4 taken from detail line 4A. With reference to FIGS. 4-4A, in some embodiments, the trocar assembly 104 may include a trocar 140 and a trocar hub 141. The trocar 140 may include an elongated tube having a distal end 142 and a proximal end 143. The diameter and length of the trocar 140 may range to match the cannula for optimized tissue cutting. The diameter of the trocar 140 may be configured such that the trocar 140 may be slidingly positioned within the lumen 124 of the cannula 120. The lumen 144 of the trocar 140 may be configured to accommodate the positioning of the stylet 160 within the lumen 144. The trocar 140 may preferably be manufactured from a medical grade stainless steel material.

[0031] The distal end 142 of the trocar 140 may include a bevel 156 and a notch 157. The bevel 156 may be configured to penetrate tissue when the trocar 140 may be inserted into the tissue of a patient. The bevel 156 may be configured as any type of tissue penetration bevel utilized in medical devices that include trocars. For example, the type of bevel 156 may be Tri-cut, Whitacre, pencil point, Seldinger, Sprotte, etc.

[0032] In some embodiments, the notch 157 may be located proximal to the bevel 156. The notch 157 may have a length that is greater than its width. The length of the notch 157 may range from 5 cm to 35 cm, including embodiments in which it is about 20 cm. The width of the notch 157 may be approximately equal to the outer diameter of the trocar 140. The depth of the notch 157 may be approximately half the outer diameter of the trocar 140. The notch 157 may be located proximal to the bevel 156. The notch 157 may comprise an open channel 158 having semicircular walls. The channel 158 may be configured to capture and hold a tissue sample that is cut or severed by the cannula (120 in FIG. 3). For example, the trocar 140 may be inserted into a target tissue or lesion. A portion of the target tissue or lesion may collapse into the channel 158. The cannula 120 may then be advanced over the trocar 140 to cut or sever a portion of the target tissue or lesion from the surrounding tissue. The cut or severed tissue sample may be captured and retained within the channel 158.

[0033] In some embodiments, the proximal end 143 of the trocar 140 may be configured to be fixedly coupled to the trocar hub 141 such that the proximal end of the lumen 144 is open to allow passage of the stylet 160 into the lumen 144. The trocar 140 may be fixedly coupled to the trocar hub 141 using techniques known in the art such as bonding, welding, overmolding, and the like. The outer surface of the proximal end 143 of the trocar 140 may be modified to enhance the bond between the trocar hub 141 and the trocar 140. For example, the surface may be chemically or mechanically etched or textured to roughen the surface to enhance adhesion of adhesives or plastics. Alternatively, the surface may be chemically modified to enhance adhesion of adhesives or plastics.

[0034] In some embodiments, the trocar hub 141 may include a body 145, a trocar coupling 146, a cavity 147, an actuation pad 148, and an actuation extension 149. The trocar hub 141 may be disposed within the proximal end of the housing base 180 and configured to move along a longitudinal axis of the housing base 180. The trocar coupling 146 may be generally cylindrical with a diameter capable of accommodating the trocar 140 and a length capable of providing a sturdy coupling between the trocar coupling 146 and the trocar 140. The trocar coupling 146 may be positioned near a distal end 150 of the body 145 of the trocar hub 141. The cavity 147 may extend from the distal end 150 of the body 145 to the proximal end 151 of the body 145. The cavity 147 may be configured to accommodate a portion of the stylet hub 161. The body 145 may further include a longitudinal slot 152 configured to allow distal and proximal movement of the stylet hub 161. An actuation extension 149 of the trocar hub 141 may extend distally from the body 145 of the trocar hub 141. The actuation extension 149 may include a hook member 153 at a distal end 154. The hook member 153 may be configured to engage a shoulder 134 of the cannula hub 121 such that proximal movement of the trocar assembly 104 results in proximal movement of the cannula assembly 102. Additionally, the hook member 153 may be configured to engage the cannula hub 121 such that the locking teeth 130 of the cannula hub 121 may be forced away from the locking teeth 183 of the housing base 180, allowing the cannula assembly 102 to move distally. An actuation pad 148 may be located at the proximal end 151 of the body 145. The actuation pad 148 may be configured for placement of a practitioner's thumb or finger when actuating the actuator 108. The actuation pad 148 may be configured to accommodate a practitioner's thumb or finger and may include a distally facing surface 155 configured to provide a non-slip surface. The surface 155 may include, but is not limited to, ridges, grooves, detents, and / or a textured surface. The trocar hub 141 may be formed from an opaque or translucent plastic material using manufacturing techniques known in the industry, such as injection molding, casting, machining, and the like.

[0035] In an embodiment, at least one portion(s) of the components of the biopsy needle device 100, including but not limited to the cannula 120, the trocar 140, and / or the stylet 160, may comprise a radiopaque material and / or an echogenic material. Radiopaque materials (e.g., in combination with computed tomography or x-ray) may assist the practitioner in guiding or displacing the biopsy needle device 100 to a desired or predetermined location within the patient's body tissue. Bismuth, gold, or other radiopaque materials alone or in combination may be used. Echogenic materials or surfaces (e.g., in combination with ultrasound) may similarly assist the practitioner in guiding or displacing the trocar assembly 104 to a desired or predetermined location within the patient's body tissue. Surface disruptions such as texturing, grooves, indentations, or combinations of materials may also be used.

[0036] In at least some instances, portions of the device may be coated, embedded, or otherwise formed with echogenic materials having different properties. For example, as shown in FIG. 5A, the trocar 240 may comprise an elongated tube having a distal end 242 and a proximal end 243. The diameter and length of the trocar 240 may range to match a cannula for optimized tissue cutting. The diameter of the trocar 240 may be configured such that the trocar 240 may be slidably placed within the lumen of the cannula. The lumen 244 of the trocar 240 may be configured to accommodate positioning of a stylet within the lumen 244. The trocar 240 may preferably be fabricated from a medical grade stainless steel material. As shown here, the distal end 242 of the trocar 240 may comprise a bevel 225 and a notch 257 in the channel 258. The bevel may be configured to penetrate the tissue when the trocar 240 may be inserted into the patient's tissue. The bevel may be configured as any type of tissue penetrating bevel utilized in medical devices with trocars. For example, the bevel type may be Tri-cut, Whitacre, pencil point, Seldinger, Sprotte, etc.

[0037] In this example, the trocar is separated into three separate portions p1, p2, p3, each of which may be coated or formed with a material having unique echogenic properties. As shown here, portion p1 is coated with a first material 261, portion p2 is coated with a second material 262, and portion p3 is coated with a third material 263, with the three materials 261-263 having different echogenicity. Although the materials 261-263 are shown in three patterns by way of illustration, it will be understood that the materials may not be perceptible to the naked eye and that the color-coded materials may only be differentiated under ultrasound. In at least some examples, the materials may include microbubbles within a biocompatible plastic coating, and the difference in echogenicity may be a percentage difference (e.g., a 10%, 20%, 30% or 40% difference in echogenicity between the materials). In at least some examples, the material may include one or more textured metals, and differences between the textures (e.g., a higher density of notches, reflectors or other surfaces featured on the textured metal) may result in differences in echogenicity and / or different colors, as described in more detail below. In at least some examples, the echogenic coating with microbubbles may be used to color code one or more devices, and portions of the device may be differentiated based on the microbubble density of respective segments. In at least some examples, the higher the density of microbubbles, the greater the echogenicity of the portion of the device coated with the microbubbles.

[0038] As shown in Fig. 6, an ultrasound device 310 may be used to image the biopsy needle 100 within tissue, and the ultrasound device 310 may communicate, via a wireless or wired connection, with a processor 320 having memory and storage, which in turn is coupled to a display 330. The processor 330 may be configured and arranged to collect images from the ultrasound probe 310 and color-code certain segments of the biopsy device based on different echogenic coatings, surface textures, and / or surface contours. For example, a portion p1 having a first echogenicity may be imaged and color-coded a first color (e.g., red) based on the first echogenicity, a portion p2 having a second echogenicity may be imaged and color-coded a second color (e.g., blue) based on the second echogenicity, and a portion p3 having a third echogenicity may be imaged and color-coded a third color (e.g., orange) based on the third echogenicity. This color coding can be sent to a display and overlaid on the raw ultrasound image such that a previously grayscale device (e.g., a biopsy needle) now appears to have three separate segments, each of which appears in a different color. In at least some examples, the display will process the color-mapped raw image or combine the raw image with color-mapped data to produce an image that is at least partially colored. It will be understood that the devices can be coated with only one material or more materials and separated into only one portion or multiple portions of different echogenicity. Additionally, separate devices can be coated with different materials so that the processor can recognize that they are separate and correlate the colors with their respective echogenicity, color-coding the separate devices and showing them in different colors on the display so that the location of the different medical devices can be quickly recognized.

[0039] Returning to FIG. 5A, color coding may be performed using other techniques. For example, as shown in FIG. 5A, three materials 261-263 may be used to create color-coded materials. Instead of having different echogenic materials or textured surfaces, the surface contours of the device may be used to provide color coding. For example, the processor 320 may be configured to recognize certain characteristics of the device based on the intended procedure. The processor's ability to recognize characteristics may include artificial intelligence or machine learning techniques. For example, the processor may be inputted with a training set, which may be a large data set that includes pictures of different types of biopsy needles from different angles. The initial data set may also include labels of different parts of the device (e.g., lumen, trocar, bevel, notch, channel, etc.). The processor may utilize feature extraction to create an algorithm that predicts certain characteristics in a device such as a biopsy needle. Using these techniques, the system may learn to identify parts of the device (e.g., the notch of a biopsy needle) and consistently color code these characteristics on the display.

[0040] In yet other examples, certain physical parameters of the device may determine the color coding. For example, the processor may be instructed to identify certain characteristics of the biopsy needle (e.g., distal and / or proximal ends) based on the echogenic focus. In some examples, the echogenic focus may consist of a focal echogenic coating and / or focal textured areas along a predetermined location on the needle. Using techniques such as artificial intelligence and deep learning, the processor software may identify and / or detect abnormal hyperechoes and use them like a map for color coding. The echogenic focus along the needle may be the same and may provide increasing echoes (i.e., increased echogenicity) from one side to the other toward the tip of the needle (e.g., increased echogenicity from the location toward the distal tip of the needle). If the system determines that the entire length of the needle is 10 cm or 16 cm, it may color code the entire length or a predetermined portion of the length. For example, the system may be configured to color code the first quarter or first 5 cm of the length of the biopsy device with a first color, the second segment segment with a second color, and so on. In Figure 5B, three focal points, f1, f2 and f3, are shown on either the distal tip of the needle and the end of the notch 257, respectively. In this example, the focal points are circumferential bands, and the system can be configured to locate these focal points and color the segment of the device between the foci a particular color (e.g., green). Thus, the system can be configured to color the segment from f1 to f2 a first color (e.g., red), from f2 to f3 a second color (e.g., green), and from f3 to the proximal end of the device a third color (e.g., blue).

[0041] 7A-B and 8A-B are photographs showing a breast mass biopsy without and with color coding and an ultrasound-guided lymph node biopsy without and with color coding. For clarity, the color-coded sections are outlined around a dashed rectangle on the display screen, which may or may not be visible to the user. As shown, the device color-codes via distinct echogenicity segments to aid the operator in identifying parts of the device relative to certain landmarks. FIGS. 9A-B are graphs showing echogenicity of the hardware coating versus percentage of returned signal and another example of a biopsy device with certain segments that correlate with the echogenicity of FIG. 9A.

[0042] Although biopsy needles have been discussed, it will be understood that other devices can be color coded as well. For example, biopsy RFID tags and / or biopsy markers can also be color coded via coating or variable material, and a processor can automatically display the tag in a particular color (e.g., red or blue) for faster and easier identification (FIG. 10). In addition, color coding can also be used for textured needles (FIGS. 11A-B). Thus, the techniques and systems described herein can be used in connection with any medical device or equipment that is placed at least partially within the body, such as suction-assisted breast biopsy devices, breast biopsy needles, biopsy clip and / or marker placement, location and removal, RFID clip and / or marker placement, location and removal, biopsies of the head, face, chest, abdomen (liver, kidney), pelvis and / or extremities, lymph node biopsies, vascular access devices (central lines, PICC lines, peripheral lines), stents, filters, angioplasty, drains and biopsy catheters.

[0043] Color-coding devices can improve the safety and accuracy of ultrasound-guided procedures. Using these techniques, physicians can, for example, better understand the location of the biopsy device tip, lowering the risk of injury to the patient (e.g., risk of causing pneumothorax or vascular injury). Physicians can also better understand the location of the biopsy trough, leading to more accurate biopsies of suspicious lesions and fewer false-negative biopsies. In at least some examples, a method of color-coding a medical procedure can include providing a medical device with at least one segment having an echogenic coating, imaging the medical device via an ultrasound probe, collecting images from the ultrasound probe via a processor, color-coding the at least one segment based on the echogenic coating, and displaying the color-coded image. In at least some examples, a method of color-coding a medical procedure can include imaging the medical device via an ultrasound probe, collecting images from the ultrasound probe via a processor, locating the medical device in the collected images and identifying at least one segment having an echogenic coating, color-coding the at least one segment based on the echogenic coating, and displaying the color-coded image.

[0044] Any method disclosed herein comprises one or more steps or actions for carrying out the described method. The steps and / or actions of the method may be interchanged with one another. In other words, unless a specific order of steps or actions is required for the correct operation of an embodiment, the order and / or use of specific steps and / or actions may be modified.

[0045] References to approximations are made throughout this specification, such as by use of the term "substantially." For each such reference, it should be understood that in some embodiments, the value, property, or characteristic may be specified without approximation. For example, when modifiers such as "about" and "substantially" are used, these terms include within their scope the modified words in the absence of those modifiers. For example, when the term "substantially upright" is stated with respect to a property, it is understood that in further embodiments, the property may have a structure that is just upright.

[0046] Similarly, in the above descriptions of the embodiments, various features are sometimes grouped together in a single embodiment, figure, or description for the purpose of streamlining the disclosure. However, this method of disclosure should not be interpreted as reflecting an intention that any claim requires more features than are expressly recited in that claim. Instead, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment.

[0047] The claims following this disclosure are hereby expressly incorporated into this disclosure, with each claim standing on its own as a separate embodiment. The disclosure includes all permutations of the independent claims and their dependent claims. Furthermore, any additional embodiments that are derivable from the independent claims and the following dependent claims are also expressly incorporated into this description.

[0048] Without the need for further elaboration, those skilled in the art can use the above description to make the most of the present disclosure. The examples and embodiments disclosed herein should be construed as merely illustrative and exemplary, and not limiting the scope of the present disclosure in any way. It will be apparent to those skilled in the art and having the benefit of this disclosure that changes may be made to the details of the embodiments described above without departing from the basic principles of the disclosure herein.

Claims

1. a biopsy needle device comprising a cannula having a distal end configured to cut a tissue sample and a trocar disposed within the cannula having a notch configured to hold a tissue sample, wherein at least one of the cannula and the trocar is divided into at least two segments comprising different echogenic coatings; An ultrasonic probe; a processor configured and arranged to collect images from the ultrasound probe and color-code the at least two segments based on at least one characteristic related to different echogenic coatings, surface textures, surface contours, and dimensions of the biopsy device; A system comprising:

2. The system of claim 1 , wherein the at least two segments comprises two segments.

3. The system of claim 1 , wherein the at least two segments comprises three segments.

4. The system of claim 1 , wherein the different echogenic coatings are based on differences in microbubble density in each coating.

5. The system of claim 1 , wherein the surface texture is based on textural differences in each coating.

6. The system of claim 1 , further comprising a display configured to visualize a color-coded image of the biopsy needle device.

7. a biopsy needle device comprising a cannula having a distal end configured to cut a tissue sample and a trocar disposed within the cannula having a notch configured to hold a tissue sample, wherein at least one of the cannula and the trocar is divided into at least two segments having related characteristics; An ultrasonic probe; a processor configured and arranged to collect images from said ultrasound probe and color code said at least two segments based on said associated characteristics; A system comprising:

8. The system of claim 7 , wherein the relevant characteristic is a surface contour, and the processor is constructed and arranged to collect images from the ultrasound probe and color code the at least two segments based on the surface contour.

9. The system of claim 7 , wherein the processor is configured and arranged to the associated characteristics based on machine learning techniques.

10. 8. The system of claim 7, wherein the processor is constructed and arranged to receive a training set and to recognize the relevant features and to predict the presence of the relevant features prior to color coding using feature extraction.

11. The system of claim 7 , wherein the processor is constructed and arranged to identify an echogenic focus and color code the at least two segments based on a location of the focus.

12. The system of claim 7 , further comprising a display configured to visualize a color-coded image of the biopsy needle device.

13. providing a biopsy needle device comprising a cannula having a distal end configured to cut a tissue sample and a trocar disposed within the cannula having a notch configured to hold a tissue sample, wherein at least one of the cannula and the trocar is split into two segments comprising different echogenic coatings; imaging the biopsy needle via an ultrasound probe; collecting images from the ultrasound probe via a processor; color-coding the two segments based on the different echogenic coatings; Displaying color-coded images The method includes:

14. 14. The method of claim 13, further comprising the step of inserting the biopsy needle into tissue, wherein imaging the biopsy needle comprises imaging the biopsy needle through the tissue.

15. 14. The method of claim 13, wherein providing the biopsy needle comprises providing different echogenic coatings based on differences in microbubble density in each coating.

16. 14. The method of claim 13, wherein providing the biopsy needle comprises providing different echogenic coatings based on differences in the texture of each coating.

Citation Information

Patent Citations

  • Biopsy needle

    JP1995250838A

  • Ultrasonic diagnostic apparatus and ultrasonic scanning method

    JP2013081764A

  • System and method for improved imaging of objects in an image

    JP2013523343A

  • A system for image-guided procedures

    JP2016509884A

  • Medical system

    JP2017074221A